company background image
A115450 logo

HLB TherapeuticsLtd KOSDAQ:A115450 Stock Report

Last Price

₩10.56k

Market Cap

₩842.7b

7D

4.5%

1Y

174.3%

Updated

13 Dec, 2024

Data

Company Financials

HLB Therapeutics Co.,Ltd.

KOSDAQ:A115450 Stock Report

Market Cap: ₩842.7b

A115450 Stock Overview

A biotech company, develops pharmaceutical products in South Korea and internationally. More details

A115450 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

HLB Therapeutics Co.,Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for HLB TherapeuticsLtd
Historical stock prices
Current Share Price₩10,560.00
52 Week High₩17,700.00
52 Week Low₩3,750.00
Beta0.0077
1 Month Change13.30%
3 Month Change17.59%
1 Year Change174.27%
3 Year Change45.03%
5 Year Change-21.99%
Change since IPO-10.58%

Recent News & Updates

Recent updates

HLB Therapeutics Co.,Ltd.'s (KOSDAQ:115450) Shares Climb 36% But Its Business Is Yet to Catch Up

Nov 18
HLB Therapeutics Co.,Ltd.'s (KOSDAQ:115450) Shares Climb 36% But Its Business Is Yet to Catch Up

What HLB Therapeutics Co.,Ltd.'s (KOSDAQ:115450) 36% Share Price Gain Is Not Telling You

Nov 18
What HLB Therapeutics Co.,Ltd.'s (KOSDAQ:115450) 36% Share Price Gain Is Not Telling You

Is HLB TherapeuticsLtd (KOSDAQ:115450) A Risky Investment?

Sep 25
Is HLB TherapeuticsLtd (KOSDAQ:115450) A Risky Investment?

What HLB Therapeutics Co.,Ltd.'s (KOSDAQ:115450) 27% Share Price Gain Is Not Telling You

Jul 22
What HLB Therapeutics Co.,Ltd.'s (KOSDAQ:115450) 27% Share Price Gain Is Not Telling You

HLB Therapeutics Co.,Ltd.'s (KOSDAQ:115450) Popularity With Investors Under Threat As Stock Sinks 26%

Jun 03
HLB Therapeutics Co.,Ltd.'s (KOSDAQ:115450) Popularity With Investors Under Threat As Stock Sinks 26%

HLB Therapeutics Co.,Ltd.'s (KOSDAQ:115450) 38% Share Price Surge Not Quite Adding Up

Apr 11
HLB Therapeutics Co.,Ltd.'s (KOSDAQ:115450) 38% Share Price Surge Not Quite Adding Up

There's Reason For Concern Over HLB Therapeutics Co.,Ltd.'s (KOSDAQ:115450) Massive 50% Price Jump

Feb 26
There's Reason For Concern Over HLB Therapeutics Co.,Ltd.'s (KOSDAQ:115450) Massive 50% Price Jump

Does G-treeBNT (KOSDAQ:115450) Have A Healthy Balance Sheet?

Mar 19
Does G-treeBNT (KOSDAQ:115450) Have A Healthy Balance Sheet?

Did Business Growth Power G-treeBNT's (KOSDAQ:115450) Share Price Gain of 134%?

Dec 21
Did Business Growth Power G-treeBNT's (KOSDAQ:115450) Share Price Gain of 134%?

Shareholder Returns

A115450KR BiotechsKR Market
7D4.5%7.0%3.1%
1Y174.3%29.7%-5.3%

Return vs Industry: A115450 exceeded the KR Biotechs industry which returned 20.7% over the past year.

Return vs Market: A115450 exceeded the KR Market which returned -5.3% over the past year.

Price Volatility

Is A115450's price volatile compared to industry and market?
A115450 volatility
A115450 Average Weekly Movement11.5%
Biotechs Industry Average Movement8.9%
Market Average Movement6.6%
10% most volatile stocks in KR Market12.6%
10% least volatile stocks in KR Market3.2%

Stable Share Price: A115450's share price has been volatile over the past 3 months compared to the KR market.

Volatility Over Time: A115450's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of KR stocks.

About the Company

FoundedEmployeesCEOWebsite
200093n/ahlbtherapeutics.co.kr

HLB Therapeutics Co.,Ltd., a biotech company, develops pharmaceutical products in South Korea and internationally. It is developing GBT-201 using Thymosin beta for the treatment of ophthalmic diseases, such as dry eye syndrome and neurotrophic keratopathy; and OKN-007 for the treatment of glioblastoma brain tumor. It is also involved in the wholesale of vaccines, as well as manufactures electrical and electronic components, such as motors, pumps, and transformers.

HLB Therapeutics Co.,Ltd. Fundamentals Summary

How do HLB TherapeuticsLtd's earnings and revenue compare to its market cap?
A115450 fundamental statistics
Market cap₩842.72b
Earnings (TTM)-₩27.91b
Revenue (TTM)₩55.30b

15.2x

P/S Ratio

-30.2x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A115450 income statement (TTM)
Revenue₩55.30b
Cost of Revenue₩47.53b
Gross Profit₩7.77b
Other Expenses₩35.68b
Earnings-₩27.91b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-349.68
Gross Margin14.06%
Net Profit Margin-50.46%
Debt/Equity Ratio10.2%

How did A115450 perform over the long term?

See historical performance and comparison